Spots Global Cancer Trial Database for A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Official Title: The Effectiveness and Safety of Polatuzumab in Real-World Clinical Practice Among Chinese Adult Patients With Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Registry Study
Study ID: NCT05954910
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the progression free survival (PFS) in the real-world settings of polatuzumab among Chinese diffuse large B cell lymphoma (DLBCL) participants.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking Union Medical College Hospital, Beijing City, , China
Peking University Third Hospital, Beijing, , China
Beijing Hospital of Ministry of Health; Hematology, Beijing, , China
Beijing Tongren Hospital, Capital Medical University, Beijing, , China
The First Bethune Hospital of Jilin University, Changchun, , China
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu City, , China
Zhujiang Hospital, Southern Medical University, Guangzhou, , China
Guizhou Cancer Hospital, Guiyang, , China
Affiliated Hospital of Inner Mongolia Medical University, Hohhot City, , China
Jiangxi Cancer Hospital, Nanchang City, , China
Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Nanjing City, , China
Jiangsu Cancer Hospital, Nanjing City, , China
Guangxi Cancer Hospital of Guangxi Medical University, Nanning City, , China
Ruijin Hospital Shanghai Jiaotong University School of Medicine; hemotology, Shanghai City, , China
Tongji Hospital of Tongji University, Shanghai, , China
China Medical University (CMU) First Affiliated Hospital, Shenyang City, , China
The Fourth Hospital of Hebei Medical University; Hematology department, Shijiazhuang, , China
Shanxi Province Cancer Hospital, Taiyuan City, , China
Tianjin Medical University General Hospital, Tianjin, , China
Tianjin Cancer Hospital, Tianjin, , China
Xinjiang Medical University Cancer Hospital, Urumqi City, , China
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan City, , China
Wuxi People's Hospital, Wuxi, , China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, , China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, , China
Henan Cancer Hospital; Oncology, Zhengzhou, , China
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
